Literature DB >> 7435544

Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks.

S Levine, R Sowinski.   

Abstract

Experimental allergic encephalomyelitis (EAE) was induced in rats by immunization with neural antigens, with or without adjuvants. A second attack was induced after an interval of 3-24 weeks. When the second attack was produced by moderately intense active immunization or by passive transfer, the rats were protected from clinical signs. Paradoxically, the second attack regularly produced more lesions in the cerebellum than in naive contols. Inhibition of clinical signs and the accompanying paradoxical enhancement of cerebellar lesions were independent of the type of antigen or adjuvant used for either attack, the severity of the attacks, and the time interval between them. Nor did non-specific adrenal-mediated stress play any role in these phenomena. Even in the absence of clinical signs, the second attack produced many lesions in the spinal cord, but these were sometimes less severe than those produced in naive controls. The observation that an initial attack of EAE had different influences on susceptibility to a second attack in different parts of the nervous system is more readily explained by local tissue factors than by systemic regulatory influences.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7435544      PMCID: PMC1903610     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The role of the adrenal in relapses of experimental allergic encephalomyelitis.

Authors:  S Levine; R Sowinski
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

2.  Do neurological signs occur in experimental allergic encephalomyelitis in the absence of inflammatory lesions of the central nervous system?.

Authors:  S Levine; R Sowinski; C M Shaw; E C Alvord
Journal:  J Neuropathol Exp Neurol       Date:  1975-11       Impact factor: 3.685

3.  INDUCTION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS WITHOUT THE AID OF ADJUVANT.

Authors:  S LEVINE; E J WENK
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

4.  [Prevention of allergic encephalomyelitis by prior injection of adjuvants].

Authors:  M W KIES; E C ALVORD
Journal:  Nature       Date:  1958-10-18       Impact factor: 49.962

5.  A study of acquired resistance to experimental allergic encephalomyelitis and of the development of the encephalitogenic brain-substance during ontogeny.

Authors:  I A SVET-MOLDAVSKAYA; G I SVET-MOLDAVSKY
Journal:  Acta Virol       Date:  1959-01       Impact factor: 1.162

6.  Myelin basic proteins of mammalian and submammalian vertebrates: encephalitogenic activities in guinea pigs and rats.

Authors:  R E Martenson; G E Deibler; M W Kies; S Levine; E C Alvord
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

7.  Allergic encephalomyelitis: cellular transformation and vascular blockade.

Authors:  S Levine
Journal:  J Neuropathol Exp Neurol       Date:  1970-01       Impact factor: 3.685

8.  Exacerbation and transformation of allergic encephalomyelitis by pertussis vaccine.

Authors:  S Levine; E J Wenk
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

9.  Hyperacute allergic encephalomyelitis. Lymphatic system as site of adjuvant effect of pertussis vaccine.

Authors:  S Levine; E J Wenk
Journal:  Am J Pathol       Date:  1967-03       Impact factor: 4.307

10.  Altered distribution of lesions after repeated passive transfers of allergic encephalomyelitis.

Authors:  S Levine; E M Hoenig; E J Wenk
Journal:  Proc Soc Exp Biol Med       Date:  1967-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.